BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Lenskart Solutions Ltd. Share Price

NSE
BSE

NSE : LENSKART

BSE : 544600

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹635.00

High

₹663.80

Price Summary

Previous Close ₹661.40
Day's Range ₹635.00 - ₹663.80
Open ₹657.80
52 Week Range ₹356.10 - ₹663.80
Volume 93,58,241
Market Cap ₹0.12
Previous Close ₹661.55
Day's Range ₹634.85 - ₹663.50
Open ₹659.45
52 Week Range ₹355.70 - ₹663.50
Volume 4,03,478
Market Cap ₹0.12

Stocks Summary

Trade Value ( ₹ in Lacs) 61,160.34
Market Cap (₹ in Mn) 0.12
Dividend Yield(%) 0.00
Price/Earning (TTM) 175.57
TTM EPS (₹) 3.77
P/E Ratio 176.10
Book Value(₹) 12.87
PAT Margin (%) 5.68
Face Value (₹) 2.00
ROCE(%) 12.55
Trade Value ( ₹ in Lacs) 2,629.49
Market Cap (₹ in Mn) 0.12
Dividend Yield(%) 0.00
Price/Earning (TTM) 175.57
TTM EPS (₹) 3.77
P/E Ratio 176.10
Book Value(₹) 12.87
PAT Margin (%) 5.68
Face Value (₹) 2.00
ROCE(%) 12.55

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 18944.6 66525.17
Expenses N/A N/A
PBT 997.2 3853.56
Operating profit 0.0 0.0
Net profit 611.7 2973.4

Shareholding Pattern

Promoters (% Holding)

17.53%

Mutual funds (% Holding)

12.20%

Non-Institution (% Holding)

46.14%

FI/Banks/Insurance (% Holding)

1.65%

Government (% Holding)

0.00%

FII

12.76%

About Lenskart Solutions Ltd.

Founded 2008
Managing Director Peyush Bansal
NSE Symbol LENSKART

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,56,089.58 1,900.90 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 2,26,975.64 8,550.00 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,85,638.53 4,880.50 3,480.60 - 3,480.60
Apollo Hospitals Enterprise Ltd. 1,24,503.13 8,659.00 6,696.50 - 6,696.50
Cipla Ltd. 1,15,216.02 1,426.20 1,165.70 - 1,165.70
Lenskart Solutions Ltd. 1,15,063.80 661.55 0.00 - 0.00
Zydus Lifesciences Ltd. 1,11,720.43 1,120.00 835.50 - 835.50
Lupin Ltd. 1,00,271.61 2,193.00 1,875.00 - 1,875.00
Dr. Reddy's Laboratories Ltd. 98,074.41 1,175.00 1,101.00 - 1,101.00
Laurus Labs Ltd. 98,047.76 1,814.65 823.10 - 823.10
no-content No Records Found

Latest News

Jul
25
2026
EQUITY Posted on Jul 25th 2026

Lenskart Solutions informs about annual report

Lenskart Solutions has informed about the Annual Report of the Company for the Financial Year 2025-26, along with the Notice convening the 18th Annual General Meeting of the Company.

The above information is a part of company’s filings submitted to BSE.

Read More
Jul
14
2026
EQUITY Posted on Jul 14th 2026

Lenskart Solutions informs about disclosure

Lenskart Solutions has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for MacRitchie Investments & PACs.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
10
2026
EQUITY Posted on Jun 10th 2026

Lenskart Solutions informs about acquisition updates

Lenskart Solutions has informed that the company has acquired an additional 3% stake in Quantduo Technologies (Quantduo or GeoIQ)). Further, the Company had earlier acquired an additional 4.65% stake in Quantduo on March 16, 2026. Accordingly, the aggregate increase in the Company's shareholding in Quantduo since the last disclosure made by the Company is 7.65%. Consequent to the aforesaid acquisitions, the aggregate shareholding of the Company in Quantduo has increased from 92.35% to 100% of the fully diluted share capital of Quantduo and consequently, Quantduo has become a wholly-owned subsidiary of the Company. The details required under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) read with SEBI Master Circular bearing reference no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed as Annexure – 1. The aforesaid details will also be hosted on the Company's website viz. https://www.lenskart.com/corporate/investorrelations.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
22
2026
EQUITY Posted on Aug 22nd 2026

Vijaya Diagnostic Centre informs about change in management

Vijaya Diagnostic Centre has informed about Cessation of Dr. Manjula Anagani as Independent Director on completion of tenure w.e.f 21.08.2026.

The above information is a part of company's filings submitted to BSE.

Read More
Aug
21
2026
EQUITY Posted on Aug 21st 2026

Indoco Remedies submits notice of 79th AGM

Pursuant to Regulation 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), Indoco Remedies has enclosed the Notice of the 79th AGM and the Annual Report for the financial year 2025- 26 for information and records. In compliance with relevant circulars issued by Ministry of Corporate Affairs and the Securities and Exchange Board of India, the Notice of the AGM along with the Annual Report will be sent by email to those Members whose email addresses are registered with the Company / Depository Participant(s). Additionally, the Notice of the AGM and the Annual Report are also being uploaded on the website of the Company at www.indoco.com. Further, in accordance with Regulation 36 of SEBI Listing Regulations, a letter providing web-link for accessing the Annual Report for the financial year 2025-26 is being sent to all those Members who have not registered their email IDs.
The above information is a part of company’s filings submitted to BSE.  
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Lenskart Solutions Ltd. ?

The current share price of Lenskart Solutions Ltd. is ₹661.40 as of 2026-08-21.

The market capitalisation of Lenskart Solutions Ltd. is ₹115,063.80 as of 2026-08-21.

The 1-year return of Lenskart Solutions Ltd. is % as of .

The P/E ratio of Lenskart Solutions Ltd. is 176.10 as of 2026-08-22.

The 52-week high and low of Lenskart Solutions Ltd. are ₹663.80 and ₹356.10, respectively, as of 2026-08-21.

The dividend yield of Lenskart Solutions Ltd. is 0.0% as of2026-08-21.

You can buy Lenskart Solutions Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Lenskart Solutions Ltd. is Peyush Bansal.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore